New! ProFound AI for DBT v3.0
The Clear Leader in Breast AI.
FDA Cleared, CE Mark Pending
Discover the Xoft Electronic Brachytherapy (eBx) System
Explore Breakthrough Technology Delivering Excellent Results
<
>
Who is iCAD?
iCAD is a global medical technology leader providing innovative cancer detection and therapy solutions. We work passionately to provide precise, powerful healthcare solutions expertly engineered to optimize operational efficiency, clinician confidence and patient outcomes.
ADVANCED CANCER DETECTION SOLUTIONSInnovative Cancer Therapy solutions
Educational Webinars
An educational webinar series featuring leading clinical experts in the fields of breast radiology and innovative cancer therapy hosted by iCAD and Xoft
Recent News
April 20, 2021
iCAD to Report First Quarter 2021 Financial Results on Wednesday, April 28
April 05, 2021
iCAD Announces Estimated Q1 Revenues and Upcoming CFO Transition
March 31, 2021
New Research Indicates ProFound AI May Reduce Interval Breast Cancer Rates
March 15, 2021
iCAD Announces FDA Clearance for ProFound AI Version 3.0 for 3D Mammography
» View All News »
CONNECT
© 2020, iCAD Inc. All rights reserved. iCAD, the iCAD logo, PowerLook, ProFound AI, ProFound, Xoft, the Xoft logo, Axxent, Electronic Brachytherapy System and eBx are trademarks of iCAD, Inc. Reproduction of any of the material contained herein in any format or media without the express written permission of iCAD, Inc. is prohibited.
